Clinical Trials Logo

Nasal Disease clinical trials

View clinical trials related to Nasal Disease.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06305520 Enrolling by invitation - Nasal Surgery Clinical Trials

Medical Device Pivotal Study to Injection With SkinPlus-HYAL Implant Lidocaine vs RESTYLANE Lidocaine in of Nasolabial Folds

BPLUS-02
Start date: March 10, 2023
Phase: N/A
Study type: Interventional

Purpose : This investigation intends to demonstrate that the investigational device, SkinPlus-HYAL Implant Lidocaine, is non-inferior to the comparator device, RESTYLANE Lidocaine, in terms of temporary wrinkle reduction effect, safety, and injection site pain when applied on nasolabial folds in adults. Design : 24-week efficacy and safety evaluation and additional 48-week long-term safety and efficacy evaluation with a multi-center, randomized, subject- & evaluator-blind, matched pairs, active controlled, none-inferiority, confirmatory design Treatment Group: Application of the investigational medical device (SkinPlus-HYAL Implant Lidocaine) Control Group: Application of the comparator device (RESTYLANE Lidocaine) Population: Number of subject 100 * In this investigation, the same subject receives both test and control treatments, one on each side of the nasolabial folds (matched pairs design).